期刊文献+

表达血管内皮生长因子-siRNA及双自杀基因yCDglyTK的联合基因载体构建及其应用研究 被引量:2

Construction of Combination Gene Vector Expressing VEGF-siRNA and Fusion Suicide Gene yCDglyTK and Its Application
下载PDF
导出
摘要 构建了新型联合基因载体pcDNA3.1(-)VEGF-siRNA/yCDglyTK,研究其在人胃癌细胞系SGC7901细胞中的表达和杀伤作用.构建靶向血管内皮生长因子(VEGF)的干扰质粒pGenesil-VEGF-siRNA,采用PCR法从中扩增siRNA表达框(含U6启动子),亚克隆至双自杀基因载体pcDNA3.1(-)CV-yCDglyTK,构建联合基因质粒pcDNA3.1(-)VEGF-siRNA/yCDglyTK;通过酶切、测序等鉴定重组质粒;以磷酸钙纳米颗粒为载体,将干扰质粒、双自杀基因质粒及联合基因质粒转染SGC7901细胞,RT-PCR、Western-blot验证目的基因表达;MTT法检测转染细胞对5-氟胞嘧啶(5-FC)的敏感性.结果表明:酶切及测序证实联合基因载体pcDNA3.1(-)VEGF-siRNA/yCDglyTK构建成功;SGC7901细胞转染联合基因质粒后,RT-PCR、Western-blot证实融合自杀基因表达,而VEGF基因表达下调;在前体药物5-FC作用下,转染联合基因组细胞存活率最低,与其他组比较有统计学差异.成功构建联合基因载体pcDNA3.1(-)VEGF-siRNA/yCDglyTK,初步验证靶向VEGF的RNA干扰与双自杀基因系统具有协同效应. This research aimed to construct a new combination gene vector: pcDNA3.1 (-)VEGF-siRNA/ yCDglyTK, study its expression quality and lethal effet in human gastric cancer cell line SGC7901. First, RNA interference (RNAi) targeting vascular endothelial growth factor (VEGF) was applied to construct interfering plasmid pGenesil-VEGF-siRNA. Then, the siRNA expression cassette (including U6 promotor ) was amplified by PCR and subcloned into pcDNA3.1 (-)CV-yCDglyTK to build a new combination gene plasmid: pcDNA3.1 (...
出处 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2010年第5期503-509,共7页 Progress In Biochemistry and Biophysics
基金 国家自然科学基金(30800518) 教育部博士点新教师基金(200805331090)资助项目~~
关键词 RNA干扰 自杀基因 胃癌 联合基因治疗 RNA interference suicide gene gastric cancer combination gene therapy
  • 相关文献

参考文献19

  • 1周海波,伍钢,彭纲,张盛,杨坤禹,王涛,顾昱.siRNA抑制VEGF基因表达对鼻咽癌细胞生物学行为的影响[J].临床肿瘤学杂志,2008,13(6):485-490. 被引量:9
  • 2刘霆,张桂英,陈玉祥,何青春,余术宜,徐美华,程军平.癌胚抗原启动子调控融合自杀基因yCDglyTK载体的构建及其应用研究[J].中国医学工程,2006,14(2):120-124. 被引量:3
  • 3Seung-Yoon P,Wan L,Jaetae L,et al.Combination gene therapy using multidrug resistance (MDR1)gene siRNA and herpes simplex virus-thymidine kinase. Cancer Letters . 2008
  • 4Pastorakova A,Hlubinova K,Altaner C.Treatment of human tumor cells by combine gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and bacterial cytosine deaminase suicide gene. Neoplasma . 2007
  • 5Shand N,Weber F,Mariani L,et al.A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir.GLI328 European-Canadian Study Group. Human Gene Therapy . 1999
  • 6Rainov NG.A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Human Gene Therapy . 2000
  • 7Byrne A M,Bouchier-Hayes D J,Harmey J H.Angiogenic and cell survival functions of vascular endothelial growth factor(VEGF). Journal of Cellular and Molecular Medicine . 2005
  • 8Hannon GJ.RNA interference. Nature . 2002
  • 9Rogulski KR,Kim JH,Kim SH,et al.Glioma cells transducedwith an Escherichia coli CD/HSV-1 TK fusion gene exhibitenbanced metabolic suicide and radiosensitivity. Human Gene Therapy . 1997
  • 10Hamstra DA,Rice DJ,Fahmy S,et al.Enzyme/prodrug therapy for head and neck cancer using a catalytically superior cytosine deaminase. Human Gene Therapy . 1999

二级参考文献12

  • 1张阳德,刘新生,张蕾,潘一峰,翟登高,张峰.纳米粒基因载体的研究现状与展望[J].中国现代医学杂志,2004,14(22):38-42. 被引量:5
  • 2Holmqvist K. The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration [ J]. Biol Chem, 2004, 279 (21) :22267 - 22275.
  • 3Reich SJ,Fosnot J,Kuroki A, et al. Small interfering RNA ( siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model[ J]. Mol Vis ,2003,9:210 - 216.
  • 4MaderJS. Bovine lactoferricin inhibits basic fibroblast growth factor-and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells[J]. Am J Pathol, 2006,169(5) : 1753 - 1766.
  • 5Achen MG,Stacker SA. Tumor lymphangiogenesis and metastatic spread-new players begin to emerge[ J]. Int J Cancer, 2006,119 (8) : 1755 -1760.
  • 6Cursiefen C. VEGF-A stimulates lymphangiogenesis andhemangiogenesis in inflammatory neovascularization via macrophage recruitment [ J ]. Clin Invest, 2004,113 (7) : 1040 - 1050.
  • 7Kucheryavykh YV. Downregulation of Kir4. 1 inward rectifying potassium channel subunits by RNAi impairs potassium transfer and glutamate uptake by cultured cortical astrocytes [ J]. Glia, 2007, 55(3) :274 -281.
  • 8Lu PY. The orphan receptor tyrosine kinase ror2 promotes osteoblast differentiation and enhances ex vivo bone formation[ J]. Mol Endocrinol, 2007, 21 (2) :376 - 387.
  • 9Schiffelers RM. Pharmaceutical prospects for RNA interference.Pharm[ J]. Res, 2004,21(1) :1 -7.
  • 10Konopatskaya O. VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice[ J]. Mol Vis, 2006,12(5) :626 -632.

共引文献9

同被引文献44

  • 1QI GuoRong Institute of Biochemistry and Cell Biology,Shanghai Institute for Biological Sciences,Chinese Academy of Sciences,Shanghai 200031,China.The background of the total synthesis of yeast alanine transfer RNA[J].Science China(Life Sciences),2010,53(1):19-21. 被引量:6
  • 2CHEN Hong1,CHEN Qun2,FANG Ming3 & MI Yan1 1 The First Affiliated Hospital of Harbin Medical University,Harbin 150101,China,2 Harbin Acheng District People’s Hospital,Harbin 150300,China,3 Graduate Department of Harbin Medical University,Harbin 150001,China.microRNA-181b targets MLK2 in HL-60 cells[J].Science China(Life Sciences),2010,53(1):101-106. 被引量:20
  • 3LUO Jun,TENG Man,FAN JianMing,WANG FangYu,ZHOU Ling,DENG RuiGuang,ZHANG GaiPing.Marek’s disease virus-encoded microRNAs: genomics, expression and function[J].Science China(Life Sciences),2010,53(10):1174-1180. 被引量:8
  • 4杨晓红,万福生,潘泽政,余波,贺慧为,艾春红,张晓春,卢小澍.RNA干扰单独及联合p53基因对肺癌细胞增殖的抑制作用[J].江西医学院学报,2006,46(6):1-3. 被引量:3
  • 5石华,杨俊霞,袁成福,易发平,魏丽丽,刘革力,马永平,宋方洲.HPV-16 E6 siRNA与hIL-24基因联合诱导人宫颈癌Ca Ski细胞的凋亡[J].肿瘤,2007,27(5):348-351. 被引量:3
  • 6Jemal A, Bray F, Center MM, Ferlay J, Ward E, For- man D. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90 [PMID: 21296855 DOI: 10.3322/ caac.20107].
  • 7Zhu X, Su D, Xuan S, Ma G, Dai Z, Liu T, Tang D,Mao W, Dong C. Gene therapy of gastric cancer us- ing LIGHT-secreting human umbilical cord blood- derived mesenchymal stem cells. Gastric Cancer 2013; 16:155-166 [PMID: 22850801 DOI: 10.1007/ s10120-012-0166-1].
  • 8Liu T, Tang A, Zhang G, Chen Y, Zhang J, Peng S, Cai Z. Calcium phosphate nanoparticles as a novel nonviral vector for efficient transfection of DNA in cancer gene therapy. Cancer Biother Radiopharm 2005; 20:141-149 [PMID: 15869447 DOI: 10.1089/ cbr.2005.20.141].
  • 9Li XH, Zhou P, Wang LH, Tian SM, Qian Y, Chen LR, Zhang P. The targeted gene (KDRP-CD/TK) therapy of breast cancer mediated by SonoVue and ultrasound irradiation in vitro. Ultrasonics 2012; 52:186-191 [PMID: 21906771 DOI: 10.1016/ j.ultras.2011.08.002].
  • 10Duarte S, Carle G, Faneca H, de Lima MC, Pierre- fite-Carle V. Suicide gene therapy in cancer: where do we stand now? Cancer Lett 2012; 324:160-170 ]PMID: 22634584 IX)I: 10.1016/j.canlet.2012.05.023].

引证文献2

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部